TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 105 filers reported holding TERNS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 4.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,646,554 | -51.1% | 1,122,842 | -52.9% | 0.00% | -60.0% |
| Q1 2024 | $15,625,237 | +4.3% | 2,381,896 | +3.2% | 0.01% | -28.6% |
| Q4 2023 | $14,977,843 | +38.6% | 2,307,834 | +7.4% | 0.01% | +40.0% |
| Q3 2023 | $10,808,570 | -16.8% | 2,148,821 | +44.7% | 0.01% | -16.7% |
| Q2 2023 | $12,990,723 | -24.7% | 1,484,654 | +1.9% | 0.01% | -33.3% |
| Q1 2023 | $17,256,255 | +126.0% | 1,457,454 | +94.3% | 0.01% | +125.0% |
| Q4 2022 | $7,635,244 | – | 750,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUPERSTRING CAPITAL MANAGEMENT LP | 956,542 | $6,514,051 | 8.21% |
| Vivo Capital, LLC | 6,182,992 | $42,106,176 | 3.89% |
| Soleus Capital Management, L.P. | 4,947,738 | $33,694,096 | 2.97% |
| ACUTA CAPITAL PARTNERS, LLC | 369,280 | $2,514,797 | 2.12% |
| GREAT POINT PARTNERS LLC | 1,149,406 | $7,827,455 | 1.50% |
| VR Adviser, LLC | 3,410,058 | $23,222,495 | 1.48% |
| Octagon Capital Advisors LP | 1,364,400 | $9,291,564 | 1.46% |
| Deep Track Capital, LP | 6,100,000 | $41,541,000 | 1.24% |
| Orbimed Advisors | 7,619,135 | $51,886,309 | 1.02% |
| Worth Venture Partners, LLC | 17,470 | $118,971 | 0.88% |